
Terlipressin injection (8.5 mL : 0.85 mg) is an intravenous synthetic vasopressin analogue primarily indicated for the treatment of bleeding esophageal varices and type 1 hepatorenal syndrome (HRS-1). Each 8.5 mL ampoule of the liquid formulation contains 1 mg of terlipressin acetate, which provides a quantitative equivalent of 0.85 mg of free terlipressin base.
Medical Uses
×